2025 Nobel Prize in Medicine Awarded for Discoveries in Regulatory T Cells and Immune Tolerance
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking work on regulatory T cells (Tregs). Their research explained how the immune system maintains 'peripheral tolerance,' preventing it from attacking the body's own tissues. They identified the Foxp3 gene as the master controller for Treg development. Mutations in this gene lead to IPEX, a severe autoimmune disease. This discovery has paved the way for new treatments for cancer, where Tregs are dismantled to allow immune attacks on tumors, and autoimmune disorders, where Treg growth is encouraged.
Key Points
- Regulatory T cells (Tregs) act as a 'security guard' to prevent the immune system from attacking healthy cells.
- The Foxp3 gene is essential for the production and function of these regulatory cells.
- The discovery helps explain why most people do not develop autoimmune conditions despite a powerful immune system.
- Clinical applications include organ transplantation and developing therapies for chronic inflammatory diseases.
Exam Facts
- The 2025 Nobel laureates are Mary E. Brunkow, Fred Ramsdell (USA), and Shimon Sakaguchi (Japan).
- IPEX is a severe autoimmune disease caused by mutations in the Foxp3 gene.
- The protein CD25 is a marker found on the surface of regulatory T cells.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.